HDAC6型
组蛋白脱乙酰基酶
生物
HDAC4型
组蛋白脱乙酰基酶5
HDAC10型
组蛋白
HDAC11型
组蛋白脱乙酰基酶2
癌症研究
乙酰化
细胞生物学
遗传学
基因
作者
Carole Seidel,Michaël Schnekenburger,Mario Dicato,Marc Diederich
出处
期刊:Epigenomics
[Future Medicine]
日期:2015-02-01
卷期号:7 (1): 103-118
被引量:195
摘要
Histone deacetylase (HDAC)6 is a member of the class IIb HDAC family. This enzyme is zinc-dependent and mainly localized in the cytoplasm. HDAC6 is a unique isoenzyme with two functional catalytic domains and specific physiological roles. Indeed, HDAC6 deacetylates various substrates including α-tubulin and HSP90α, and is involved in protein trafficking and degradation, cell shape and migration. Consequently, deregulation of HDAC6 activity was associated to a variety of diseases including cancer, neurodegenerative diseases and pathological autoimmune response. Therefore, HDAC6 represents an interesting potential therapeutic target. In this review, we discuss structural features of this histone deacetylase, regulation of its expression and activity, biological functions, implication in human disease initiation and progression. Finally will describe novel and selective HDAC6 inhibitors.
科研通智能强力驱动
Strongly Powered by AbleSci AI